Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Zomedica Corp. Common Shares
(NY:
ZOM
)
0.0973
UNCHANGED
Last Price
Updated: 8:00 PM EST, Mar 4, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Zomedica Corp. Common Shares
< Previous
1
2
3
4
5
6
Next >
Why Is Zomedica (ZOM) Stock Up Today?
↗
January 18, 2023
Zomedica (ZOM) stock is on the rise Wednesday after the company signed a strategic restructuring agreement with Qorvo Biotechnologies.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
January 18, 2023
We're starting the day with a breakdown of the biggest pre-market stock movers traders will want to watch on Wednesday morning!
Via
InvestorPlace
10 Best Medical Stocks Under $5
↗
October 29, 2022
The medical industry is one of the most lucrative sectors globally, and it is one that sees the highest spending in terms of research and development, and breakthrough advances through keeping up the...
Via
Talk Markets
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
October 13, 2022
Good morning, investor! We're starting off Thursday with a breakdown of the biggest pre-market stock movers this morning!
Via
InvestorPlace
ZOM Stock Pops 5% as Zomedica Acquires Revo Squared
↗
July 06, 2022
ZOM stock is on the rise as Zomedica acquires crucial technology that will provide veterinarians with enhanced diagnostic imaging quality.
Via
InvestorPlace
Dogs Win, Investors Lose With Zomedica
↗
March 24, 2022
Zomedica still has cash from pushing its Truforma device last year, but the future of ZOM stock is based on PulseNet, bought in October.
Via
InvestorPlace
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
January 06, 2023
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.
Via
Benzinga
Why Zoom Video Is Trading Lower By 11%; Here Are 28 Stocks Moving Premarket
↗
August 23, 2022
Gainers Quotient Limited (NASDAQ: QTNT) shares rose 58.2% to $0.3070 in pre-market trading. Quotient recently reported a wider Q1 loss.
Via
Benzinga
It’s Going to Take a Lot to Get Zomedica Stock Out of the Doghouse
↗
March 09, 2022
ZOM stockholders are likely to grow increasingly frustrated with management's misplaced optimism and the lack of Truforma sales.
Via
InvestorPlace
Zomedica’s Shareholders Should Be Worried About the Outlook of ZOM Stock
↗
February 16, 2022
ZOM stock has been a toxic asset for nearly a year, and Zomedica isn't giving investors much to get enthused about.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023
↗
January 06, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
December 22, 2022
Thursday's session saw 329 companies set new 52-week lows.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
August 23, 2022
Good morning! It's time for a breakdown of the biggest pre-market stock movers for Tuesday and the news that has them moving.
Via
InvestorPlace
Why GreenBox POS Is Trading Higher By Around 72%, Here Are 70 Stocks Moving In Tuesday's Mid-Day Session
↗
August 16, 2022
Gainers GreenBox POS (NASDAQ: GBOX) shares jumped 72.4% to $2.19 as the company reported better-than-expected Q2 sales.
Via
Benzinga
This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday
↗
August 17, 2022
Gainers Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids.
Via
Benzinga
Here's What's Going On With Zomedica Shares
↗
August 16, 2022
Zomedica Corp (NASDAQ: ZOM) shares are trading lower by 13.9% to $0.32 Tuesday morning after the company reported second-quarter earnings results. What Happened?
Via
Benzinga
Coinbase, Moderna And 56 Biggest Movers From Yesterday
↗
July 07, 2022
Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares climbed 75.2% to close at $2.19 after the company announced it has developed a non-invasive blood sensor designated to alert real-time...
Via
Benzinga
Why Is SCWorx (WORX) Stock Up 37% Today?
↗
July 06, 2022
SCWorx (WORX) stock is rocketing higher on Wednesday after boosting investor confidence with a stock purchase agreement!
Via
InvestorPlace
Why Zomedica Shares Are Falling Today
↗
May 11, 2022
Zomedica Corp (NASDAQ: ZOM) shares are trading lower by 4.99% at $0.20. The company reported first-quarter earnings results during Tuesday’s after-hours session. Zomedica reported a first-quarter EPS...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
April 28, 2022
During Thursday, 849 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
April 27, 2022
Wednesday's session saw 784 companies set new 52-week lows.
Via
Benzinga
Continue to Steer Clear of MULN Stock
↗
April 27, 2022
Small-cap, battleground EV play MULN stock could deliver a blow to bears, but for today investors should simply avoid a poor investment.
Via
InvestorPlace
Earnings Scheduled For May 10, 2022
↗
May 10, 2022
Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.
Via
Benzinga
Will the PulseVet Acquisition Continue to Deliver Sales for Zomedica?
↗
March 03, 2022
ΖΟM stock is a penny stock that is trying to make a turnaround. A positive catalyst is present in the form of sales growth.
Via
InvestorPlace
Earnings Scheduled For February 25, 2022
↗
February 25, 2022
Companies Reporting Before The Bell • ACM Research (NASDAQ:ACMR) is estimated to report quarterly earnings at $0.64 per share on revenue of $89.53 million. •...
Via
Benzinga
My Top Things To Expect This Week
↗
February 22, 2022
This week will bring earnings that give insight into multiple investment themes and other important events that you should watch out for.
Via
InvestorPlace
26 Stocks Moving in Friday's Pre-Market Session
↗
February 18, 2022
Gainers Energy Vault Holdings, Inc. (NYSE: NRGV) rose 34.2% to $14.90 in pre-market trading after jumping around 14% on Thursday. Energy Vault Holdings recently started...
Via
Benzinga
Zomedica Stock Should Have Popped on This Latest Acquisition, so Beware
↗
January 21, 2022
So when an intriguing acquisition has failed to boost ZOM stock, investors should ask why that’s the case.
Via
InvestorPlace
3 Most-Shorted Stocks at 52-Week Lows to Buy
↗
January 07, 2022
In a market made up of stocks, these three most-shorted stocks look poised to deliver a much happier 2022 to bullish investors.
Via
InvestorPlace
56 Biggest Movers From Yesterday
↗
February 17, 2022
Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) gained 54.5% to close at $2.07 on Wednesday. Hookipa Pharma amended and restated collaboration and license agreement with Gilead...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today